PDS5A
Basic information
Region (hg38): 4:39822863-39977956
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDS5A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 40 | 41 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 42 | 2 | 0 |
Variants in PDS5A
This is a list of pathogenic ClinVar variants found in the PDS5A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-39838008-A-C | not specified | Uncertain significance (Jul 25, 2023) | ||
4-39838037-C-G | not specified | Uncertain significance (May 16, 2023) | ||
4-39838039-G-C | not specified | Uncertain significance (Sep 22, 2023) | ||
4-39838108-G-C | not specified | Uncertain significance (Apr 26, 2023) | ||
4-39844695-A-C | not specified | Uncertain significance (Jan 20, 2025) | ||
4-39844720-T-C | not specified | Likely benign (Apr 15, 2024) | ||
4-39844774-C-T | not specified | Uncertain significance (Sep 19, 2022) | ||
4-39844779-C-T | not specified | Uncertain significance (Jan 28, 2025) | ||
4-39844800-G-A | not specified | Uncertain significance (May 25, 2022) | ||
4-39848909-T-C | not specified | Uncertain significance (Aug 21, 2023) | ||
4-39848930-T-C | not specified | Uncertain significance (Jan 10, 2022) | ||
4-39848939-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
4-39848942-A-C | not specified | Uncertain significance (May 16, 2023) | ||
4-39849596-G-T | not specified | Uncertain significance (Dec 02, 2022) | ||
4-39862226-T-G | not specified | Uncertain significance (Apr 08, 2024) | ||
4-39862889-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
4-39862939-G-C | not specified | Uncertain significance (Jan 22, 2025) | ||
4-39863031-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
4-39863454-G-C | not specified | Uncertain significance (Dec 07, 2022) | ||
4-39866944-C-A | not specified | Uncertain significance (Mar 04, 2024) | ||
4-39866946-G-A | not specified | Uncertain significance (Jul 18, 2024) | ||
4-39866988-T-C | not specified | Uncertain significance (Jan 19, 2024) | ||
4-39869405-C-T | not specified | Uncertain significance (May 05, 2023) | ||
4-39869421-T-G | not specified | Uncertain significance (Dec 27, 2023) | ||
4-39873039-T-C | not specified | Uncertain significance (Dec 19, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDS5A | protein_coding | protein_coding | ENST00000303538 | 32 | 155094 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000220 | 124632 | 0 | 6 | 124638 | 0.0000241 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 5.05 | 287 | 649 | 0.442 | 0.0000318 | 8787 |
Missense in Polyphen | 57 | 220.2 | 0.25886 | 3199 | ||
Synonymous | 0.827 | 215 | 231 | 0.931 | 0.0000115 | 2463 |
Loss of Function | 6.81 | 7 | 67.2 | 0.104 | 0.00000366 | 925 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000477 | 0.0000464 |
European (Non-Finnish) | 0.0000356 | 0.0000354 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. May couple sister chromatid cohesion during mitosis to DNA replication. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. {ECO:0000269|PubMed:15855230, ECO:0000269|PubMed:19907496}.;
- Pathway
- Establishment of Sister Chromatid Cohesion;S Phase;Mitotic Prometaphase;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;Cohesin Loading onto Chromatin;Mitotic Telophase/Cytokinesis;M Phase;Cell Cycle;Resolution of Sister Chromatid Cohesion;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 15.2
Haploinsufficiency Scores
- pHI
- 0.684
- hipred
- Y
- hipred_score
- 0.765
- ghis
- 0.649
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.848
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pds5a
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; craniofacial phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- DNA repair;mitotic sister chromatid cohesion;negative regulation of DNA replication;cell division
- Cellular component
- chromosome, centromeric region;chromatin;nucleus;nucleoplasm;chromosome;cytosol;plasma membrane
- Molecular function
- protein binding